HEALTH PROFESSIONALS’ AWARENESS ABOUT PHARMACOVIGILANCE SYSTEM IN BULGARIA
Tatyana Benisheva-Dimitrova¹, Petya Trendafilova¹, *Valentina Petkova², Dobriana Sidjimova¹, Emilia Naseva¹
¹Faculty of Public Health, Medical University –Sofia, Sofia, Bulgaria.
²Faculty of Pharmacy, Medical University –Sofia, Sofia, Bulgaria.
ABSTRACT
Statistics show that about 6% of hospital admissions are due to adverse
drug reactions (ADRs) and over 50% of them could have been
avoided. In accordance with European and national regulatory changes
related to the pharmacovigilance system since 2012, the issue of
medical professionals’ awareness on the given topic is extremely
important. The annual reports of the BDA website for the period 2000-
2012 refer to the low average of ADRs reporting among health
professionals and it proves thatmedical specialists in Bulgaria do not
realize the importance and necessity of ADRs reporting in order to
ensure and maintain safe and effective medicinal products. A pilot
study has been undertaken in order to investigate medical professionals’ awareness in
Bulgaria about the importance of adverse drug reactions reporting. Pharmacovigilance is
defined as a system for collecting, monitoring, researching and evaluating information by the
healthcare professionals, marketing authorisation holders and patients. In this survey
undertaken in 2013 among 143 health professionals regarding pharmacovigilance system, a
significant awareness of 61.5% of the respondents was found. More than half of the surveyed
health professionals are familiar with the reporting rules and regulations, regardless the low
frequency of reporting for the country, published in the annual reports of the Bulgarian Drug
Agency (BDA) The highest share of pharmacovigilance knowledge is among the
pharmacists, followed by assistant pharmacists and the medical doctors. Regarding the
procedure for adverse drug reactions reporting the proportion of respondents who answered
correctly was 85.3% or 122 participants in the study indicated that this is by completing the “Yellow card” provided by the BDA.
Keywords: Pharmacovigilance, health professionals, adverse drug reactions,awareness.
[Download Article]
[Download Certifiate]